News

BAML and Lazard lead Johnson & Johnson’s Actelion takeover

$30bn biotech acquisition is the largest deal announced so far this year

  $30bn biotech acquisition is the largest deal announced so far this year
$30bn biotech acquisition is the largest deal announced so far this year Photo: Getty Images

Bank of America Merrill Lynch and Lazard have emerged with lead advisory roles on the largest takeover announced so far in 2017.

US healthcare group Johnson & Johnson has agreed a $30 billion acquisition of Actelion, a Swiss biotech business, according to a joint statement from the companies on January 26.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump